International Stroke Conference 2025
/
Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)
Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)